Retinal Neurovascular Coupling in Patients Previously Infected With COVID-19
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorMedical University of Vienna
About this trial
The Study objective is to measure retinal neurovascular coupling and blood flow parameters in patients previously infected with COVID-19, long COVID-19 and healthy age- and sex- matched control subjects
Eligibility criteria
Qualifiers
Men and women aged over 18 years
Non-smokers
Normal findings in the medical history unless the investigator considers an abnormality to be clinically irrelevant
No previous history of COVID-19 infection
Disqualifiers
Symptoms of a clinically relevant illness in the 3 weeks before the first study day
Presence or history of a severe medical condition as judged by the clinical investigator
Participation in a clinical trial in the 3 weeks preceding the study
Blood donation during the previous three weeks
Trial design
Treatments tested in this trial
- Dynamic Vessel Analyzer (DVA)
- Fourier domain optical coherence tomography (FDOCT)
- Optical coherence tomography (OCT)
- Laser Speckle Flowgraphy (LSFG)
- Proteomics and Metabolites in Plasma, tear fluid and finger sweat
Treatment groups
90 Participants
are divided into 3 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov